← Open Payments lookup

MITTAL PATEL: Open Payments

NPI 1093229619 · BELLEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$187 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $121 · 2025 $187

Food & beverage: $187
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation3$79
Grifols USA, LLC1$24
Cycle Pharmaceuticals Inc1$21
Takeda Pharmaceuticals U.S.A., Inc.1$17
Regeneron Healthcare Solutions, Inc.1$17
ARS Pharmaceuticals Operations, Inc.1$14
GlaxoSmithKline, LLC.1$14

Products named: Rhapsido, Xembify, Sajazir, CUVITRU, DUPIXENT, NEFFY, NUCALA.

Industry payments across NJ — which companies pay providers there.